Movers & shakers

Steve Williams is a consultant pharmacist in medicine and medication safety at University Hospital of South Manchester NHS Foundation Trust. Nicola Cree talks to him about his role and the future developments of medicine safety

One year into their appointments as national clinical directors for pharmacy, Jonathan Mason and Martin Stephens speak to Dawn Connelly about progress on implementing England’s pharmacy White Paper and their hopes for the future

Jeremy Holmes will leave his post as Chief Executive and Registrar of the Royal Pharmaceutical Society when the organisation separates next year into a new regulator and professional body for pharmacy. Olivia Timbs asked him about his time at the helm and his hopes for the profession’s future

Malcolm Stevens has had a super-successful career in pharmacy academia and his achievements include the discovery of a blockbuster anticancer drug. Francesca Rivers spoke to him about the direction in which his chosen career path in pharmacy has taken him

Pharmaceutical needs assessments will soon be a vital part of control of entry regulations. Will this protect proprietors from competition or is it good news for buyers, Gareth Malson, editor of PJ Business Knowledge, asked Steve Lutener, of the Pharmaceutical Services Negotiating Committee

Bob Nicholls was recently appointed chairman designate of the General Pharmaceutical Council. Francesca Rivers spoke to him about the task ahead

The General Pharmaceutical Council, pharmacy’s new regulator, opens its doors next year. Francesca Rivers spoke to Keith Ridge, chief pharmaceutical officer for England, and Liz Dimond, head of pharmacy regulation at the Department of Health about how the regulator is progressing

Following the recent decision of the Royal Pharmaceutical Society’s Council not to challenge the proposals in the draft Pharmacy Order 2009 to restrict the title of “pharmacist” to General Pharmaceutical Council registrants, Nicola Cree talks to Steve Churton, the Society’s President

The loss of short-line wholesalers could result in a loss of competition between generics manufacturers, hence a loss of purchasing profit for pharmacies.

Retail Round-up interviews Paul Forster-Jones about the nature of the threat

Dawn Connelly talks to Jonathan Mason, the national clinical director for primary care and community pharmacy in England, about how he plans to champion the development of pharmaceutical services in the community